Dual-targeted inhibitors of BET bromodomains and PI3-kinase for cancer therapy.

Shortt, Jake (Primary Chief Investigator (PCI))
Thompson, Philip (Chief Investigator (CI))

Project: Research

Status	Finished
Effective start/end date	1/02/22 → 1/02/24

FlowCore
Andrew Fryga (Manager)
Faculty of Medicine Nursing and Health Sciences Research Platforms
Facility/equipment: Facility